Rubella Antibodies, IgG

Rubella Antibodies, IgG (anti‑rubella IgG; German measles antibodies) is used to establish immunity following prior infection or immunization, including routine preconception and antenatal assessments. It also identifies individuals without immunity who may benefit from vaccination. In addition, the test helps clarify equivocal or discordant serologic results and supports evaluation of neonates for possible congenital rubella when maternal infection during pregnancy is suspected or confirmed.

Following acute rubella, IgM appears first, whereas rubella‑specific IgG develops later and generally remains detectable for life, indicating prior infection or vaccine‑induced immunity. Rubella is a typically mild, self‑limited rash illness transmitted via respiratory droplets. However, primary infection in the first trimester is associated with a high risk of miscarriage, stillbirth, or congenital rubella syndrome featuring multisystem involvement, including sensorineural hearing loss, cataracts, cardiac anomalies, microcephaly, and hepatic disease. IgG seropositivity supports immune protection due to prior exposure or vaccination. Immunoblot techniques can demonstrate antibodies directed against individual rubella viral antigens, which may help characterize the pattern of the immune response.